🇯🇵
Japan
680 companies trackedJapan is Asia's most mature biotech market with a strong regulatory framework (PMDA) and deep expertise in regenerative medicine. The country was the first to approve iPSC-derived cell therapies.
Companies
680
Total Raised
$8.4B
Top Stage
Phase 2
Top Focus
Cell Therapy
📍 Tokyo📍 Osaka📍 Kobe📍 Tsukuba
🇯🇵
Coming soon
We're tracking 680 companies in Japan — data is being loaded.
Want early access?
🌍 Nearby countries
Are you a Japan biotech?
Claim your profile for free — control your company page, post updates, and connect with investors.
